Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol PK in CF Pulmonary Exacerbations
NCT05314764Phase 4Completed
- Sponsor
- Hartford Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefiderocol in bacterial pneumonia, sponsored by Hartford Hospital. Started Jun 2022; status: completed.
02
Drugs
cefiderocol
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on NCT05314764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314764.